Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Glaukos completes Avedro buy

November 21, 2019 By Danielle Kirsh

Glaukos logoGlaukos (NYSE:GKOS) today said it completed its acquisition of Avedro for an undisclosed amount.

Avedro develops single-use drug formulations that are designed to strengthen corneal tissues and stop the progression of degenerative corneal ectatic disease keratoconus.

“Today marks an important day for Glaukos as Avedro will serve as the cornerstone of our new corneal health franchise,” Glaukos president and CEO Thomas Burns said in a news release. “This transaction airs two highly complementary, hybrid pharma and device organizations, combining Avedro’s novel bio-activated pharmaceutical solutions and R&D capabilities with Glaukos’s global commercial scale, proven market-building and shared reimbursement expertise and extensive clinical and regulatory infrastructure. We’re excited to welcome the talented Avedro employees to the Glaukos organization to help build upon our solid foundation to transform Glaukos into a global ophthalmic pharmaceutical and device leader capable of serving the vision care needs of physicians and their patients for years to come.”

Glaukos announced in August that it would be buying Avedro in an effort to build out its corneal health franchise.

Shares in GKOS were up 0.31% to $63.29 apiece in mid-morning trading.

Filed Under: Featured, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Avedro Inc., Glaukos

IN CASE YOU MISSED IT

  • W.L. Gore officials think they can spur insulin delivery system innovation
  • Leo Pharma, Portal Instruments partner to develop needle-free drug delivery device
  • J&J’s Ethicon launches Vistaseal fibrin sealant
  • Senseonics launches Eversense CGM System with non-adjunctive claim
  • ‘Hubble Space Telescope’ for genomics could yield new drugs, materials
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookDrug Delivery Business News
Follow us on Twitter@DrugDeliveryNow
Connect with us on LinkedInLinkedIn

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS